Intech Investment Management LLC Boosts Stake in Oscar Health, Inc. $OSCR

Key Points

• Intech Investment Management LLC increased its stake in Oscar Health by 50.3%, acquiring 46,748 additional shares, bringing its total to approximately 139,600 shares valued at $1.83 million.
• The stock of Oscar Health has experienced fluctuations, recently trading down 4.3% and has a twelve-month range between $11.20 and $23.79.
• Recent analyst ratings indicate a cautious outlook, with target prices dropped by firms like Piper Sandler and Barclays, and an average analyst rating of "Strong Sell" with a consensus price target of $12.07.

Intech Investment Management LLC boosted its stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 50.3% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 139,600 shares of the company's stock after buying an additional 46,748 shares during the period. Intech Investment Management LLC owned approximately 0.06% of Oscar Health worth $1,830,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Jones Financial Companies Lllp boosted its stake in shares of Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock worth $30,000 after buying an additional 2,242 shares during the last quarter. Larson Financial Group LLC increased its holdings in shares of Oscar Health by 83,733.3% in the first quarter. Larson Financial Group LLC now owns 2,515 shares of the company's stock worth $33,000 after purchasing an additional 2,512 shares during the last quarter. CWM LLC increased its holdings in shares of Oscar Health by 50.7% in the first quarter. CWM LLC now owns 3,204 shares of the company's stock worth $42,000 after purchasing an additional 1,078 shares during the last quarter. Caitong International Asset Management Co. Ltd grew its position in Oscar Health by 484.6% in the first quarter. Caitong International Asset Management Co. Ltd now owns 3,443 shares of the company's stock worth $45,000 after acquiring an additional 2,854 shares in the last quarter. Finally, Cliffwater LLC purchased a new position in Oscar Health in the first quarter worth about $58,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Stock Performance

Shares of OSCR traded down $0.15 during trading hours on Friday, reaching $18.96. 11,812,860 shares of the company traded hands, compared to its average volume of 13,934,137. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.79. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 0.26. The stock has a market capitalization of $4.90 billion, a P/E ratio of -23.33 and a beta of 1.87. The business has a fifty day moving average price of $16.10 and a 200-day moving average price of $15.25.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The company reported ($0.89) EPS for the quarter, beating the consensus estimate of ($0.90) by $0.01. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The company had revenue of $2.86 billion for the quarter, compared to analyst estimates of $2.88 billion. During the same period in the prior year, the company earned $0.20 earnings per share. The firm's revenue was up 29.0% on a year-over-year basis. Equities analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. Raymond James Financial lowered Oscar Health from an "outperform" rating to a "market perform" rating in a research report on Tuesday, June 24th. Piper Sandler reduced their price objective on shares of Oscar Health from $14.00 to $13.00 and set a "neutral" rating for the company in a research note on Thursday, August 14th. UBS Group reissued a "sell" rating and issued a $11.00 price objective (down previously from $15.00) on shares of Oscar Health in a research note on Tuesday, July 15th. Baird R W downgraded shares of Oscar Health from a "strong-buy" rating to a "hold" rating in a research note on Friday, July 25th. Finally, Barclays reduced their price objective on shares of Oscar Health from $17.00 to $11.00 and set an "underweight" rating for the company in a research note on Wednesday, July 23rd. Four research analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the company. According to MarketBeat, Oscar Health has an average rating of "Strong Sell" and an average price target of $12.07.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.